Valuing multistage investment projects in the pharmaceutical industry
From MaRDI portal
Publication:724168
DOI10.1016/j.ejor.2018.05.044zbMath1403.91384OpenAlexW2805452986MaRDI QIDQ724168
James S. Dyer, Gláucia Fernandes, Luiz E. Brandão
Publication date: 25 July 2018
Published in: European Journal of Operational Research (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1016/j.ejor.2018.05.044
Related Items (2)
Consistency between principal and agent with differing time horizons: computing incentives under risk ⋮ A real options based decision support tool for R\&D investment: application to CO\(_2\) recycling technology
Cites Work
- Evaluating pharmaceutical R\&D under technical and economic uncertainty
- Arithmetic Brownian motion and real options
- Real options game models of R\&D competition between asymmetric firms with spillovers
- A real options game of alliance timing decisions in biopharmaceutical research and development
- Quality uncertainty and quality-compensation contract for supply chain coordination
- A model of R\&D valuation and the design of research incentives
- R&D Investments with Competitive Interactions
This page was built for publication: Valuing multistage investment projects in the pharmaceutical industry
